Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4372)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 15, 2024 (publication date) through Apr 16, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lei XT, Pu DL, Shan G, Wu QN. Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy. World J Diabetes 2024; 15(6): 1070-1073 [PMID: 38983803 DOI: 10.4239/wjd.v15.i6.1070] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Lei XT, Pu DL, Shan G, Wu QN. Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy. World J Diabetes 2024; 15(6): 1070-1073 [PMID: 38983803 DOI: 10.4239/wjd.v15.i6.1070] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i6/1070.htm |
| Number | Citing Articles |
| 1 |
Hongbing Wan, Xiuxiu Xu, Dasong Yi, Kexin Shuai. Real-world safety evaluation of atorvastatin: insights from the US FDA adverse event reporting system (FAERS). Expert Opinion on Drug Safety 2025; 24(3): 305 doi: 10.1080/14740338.2024.2424438
|
| 2 |
Victor Gurevich, Andrey Obrezan. Cardiovascular Toxicity. Advances in Biochemistry in Health and Disease 2025; 33: 217 doi: 10.1007/978-3-031-90598-8_11
|
| 3 |
Shan Lin, Bangwei Wu, Shengjia Sun, Tao Sun. PCSK9 Inhibitor Alirocumab Improves Diabetic Cardiomyopathy Through the ERK/p38 MAPK Signaling Pathway. International Journal of Molecular Sciences 2026; 27(5): 2341 doi: 10.3390/ijms27052341
|
| 4 |
Wansheng Qiu, Wei Gao, Lingyan Li, Xiaoyan Guo, Dandan Liu, Weiwei Liu, Xiong Yang. Association between statin use and major adverse cardiovascular events in patients with chronic kidney disease and cardiomyopathy: A retrospective case-control study. Medicine 2026; 105(12): e47874 doi: 10.1097/MD.0000000000047874
|
| 5 |
Betül İşiner, Aslı Fahriye Ceylan, Büşra Görgün, Leyla Didem Kozacı. Dose-dependent effects of atorvastatin on inflammatory response in endothelial cells: MMP/TIMP balance and in vitro wound closure assay. BMC Molecular and Cell Biology 2026; 27(1) doi: 10.1186/s12860-026-00573-z
|